| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Raben David is a Chief Medical Officer at Bicara Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | BCAX Bicara Therapeutics Inc. | Chief Medical Officer | Sale+OE | 5,500 | $22.88 | $125,830.10 | -9.0% | - | - | |
| Mar 25, 2026 | BCAX Bicara Therapeutics Inc. | Chief Medical Officer | Sale+OE | 5,500 | $18.95 | $104,229.40 | -9.0% | - | - | |
| Nov 25, 2025 | BCAX Bicara Therapeutics Inc. | Chief Medical Officer | Sale+OE | 11,000 | $18.65 | $205,108.20 | -9.4% | -11.2% | - | |
| Oct 9, 2025 | BCAX Bicara Therapeutics Inc. | Chief Medical Officer | Sale+OE | 22,000 | $18.45 | $405,900.00 | -38.3% | -6.0% | - |